Related content

mTOR inhibition in breast cancer: unraveling the complex mechanisms of mTOR signal transduction and its clinical implications in therapy

By O'Regan Ruth   Hawk Natalyn Nicole  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 7, 2011-07 ,pp. : 859-872

Informa Healthcare

Access to resources Recommend Favorite

mTOR Pathway and mTOR Inhibitors as Agents for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 8, Iss. 8, 2008-12 ,pp. : 647-665

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with PI3K/AKT/mTOR Signaling

By  

Current Cancer Drug Targets, Vol. 13, Iss. 2, 2013-02 ,pp. : 188-204

Bentham Science Publishers

Access to resources Recommend Favorite

mTOR Inhibitors: Facing New Challenges Ahead

By  

Current Medicinal Chemistry, Vol. 18, Iss. 18, 2011-06 ,pp. : 2743-2762

Bentham Science Publishers

Access to resources Recommend Favorite

An overview of the mTOR pathway as a target in cancer therapy

By Gentzler Ryan D   Altman Jessica K   Platanias Leonidas C  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 5, 2012-05 ,pp. : 481-489

Informa Healthcare

Access to resources Recommend Favorite